menu toggle
COVID-19 : 리소스 센터 (자료 센터)
COVID-19에 대한 World Courier의 운영 업데이트 및 포괄적인 정보를 확인하십시오.

Manufacturer Solutions

Manufacturer operations, replenishment and DSCSA support

Ensuring a smooth and efficient supply chain

By streamlining packaging and logistics guidelines for our manufacturer partners, we ensure sites of care receive their products quickly and safely. Healthcare providers and patients alike rely on our ability to receive your products, process and ship them quickly from our 30+ state-of-the-art distribution centers–and to do it in a manner that prioritizes patient safety and product access. 

Manufacturer logistics guide

DSCSA support for manufacturers

Product packaging and labeling

Product setup and master data

Manufacturer data exchange

DSCSA Support for Customer/Dispensers


Manufacturer logistics guide

Our Manufacturer Logistics Guide defines how to engage with AmerisourceBergen and our requirements for establishing and maintaining effective product movement. We have developed these guidelines with input from our trading partners, internal stakeholders and industry standards and alliance bodies.  As best practices evolve, this document will be revised.

DSCSA support for manufacturers

We want to ensure your products are not only in compliance with DSCSA, but also, our distribution centers and pharmacy customers begin to use serialized products, that the barcodes and packaging can be scanned and utilized.  We also want to continue to support our trading partners as we reach new DSCSA milestones.

Meeting 2023 Requirements

AmerisourceBergen (AB) intends to be fully compliant with the enhanced unit level tracking requirements by November 2023. At this time, AB does not believe the Food and Drug Administration (FDA) will provide any additional enforcement discretion. In partnership with our manufacturer partners, there are several key milestones that AB must hit to meet the November 2023 deadline while not disrupting patient access 

January 5, 2023: Please carefully review the new position paper below. We have more clearly defined our operational processes that will go into effect in alignment with implementation.

Read the January 2023 position letter

April 2023 DSCSA FAQs Document

HDA Best Practices Considerations for Manufacturer DSCSA Data Quality

2018 Serialization

AmerisourceBergen will accept un-serialized product for the foreseeable future under the Grandfathering Policy. It’s our policy to reference the manufacturer’s DSCSA transaction statement as proof that the manufacturer is complying with all legal requirements.  

Saleable Returns

Starting November 27, 2019, all saleable returns from our customers must have the Product Identifier, if not grandfathered, verified with the original manufacturer. AmerisourceBergen manages over 13.5 million saleable returns a year and cannot rely on phone calls, emails or individual portals to execute verification requests. Please read the following related letters.
Preparing for Serialization: Read the letter
DSCSA 2020 Saleable Returns FDA Enforcement Discretion: Read the letter


As we transition to serialized data exchange and implement a VRS for 2019 Saleable Returns, we will need to collect all historical data about existing products and ensure that we collect accurate data for all new product launches going forward. We will be working with our trading partners to gather GTINs via HDA’s Origin, GDSN and other applicable methods to electronically collect this data.  


DSCSA Pilot Activity

2015 GS1: Visit Here
2017 HDA Saleable Returns Pilot: Read Here
2018 Exceptions Pilot: Download Now
2019 MediLedger DSCSA FDA Pilot: Download Now
2019 Xavier End to End Serialization FDA Pilot: Download Now

LSPediA Investigator Tool

The LSPediA Investigator tool enables AmerisourceBergen to notify our manufacturer partners about suspect product and saleable returned product with non-response or negative verifications. This provides a way for the manufacturer partner to respond to these inquiries in a streamlined process with an audit trail.

Here are some useful links:

In 2020, AmerisourceBergen is sponsoring notification accounts for the top 100 suppliers in terms of saleable returns volume. To verify if you qualify for this, please check here Top 100 Inquiry Form

To register users for a notification account, please use the following links according to the option that is applicable to your company:

We ask that every trading partner reach out to our Secure Supply Chain team now and let us know the following:

  1. What is your method for automating the 2019 Saleable Returns Verification 
    (sending data, or VRS)?
  2. Do you want to know your average saleable return volume?
  3. How can we get your historic master data?
  4. Do you still need serialized labels reviewed?
  5. Do you want to pilot sending EPCIS data?
  6. Do you have any other general questions?

Product packaging and labeling

Product labeling and packaging is critical to ensure efficient and safe product movement through the supply chain.  Just as important as the physical product packaging itself, logistics and transportation are also vital in ensuring the product arrives undamaged, and as efficiently as possible. As part of our Manufacturer Logistics guide, we examined industry best practices to outline both our requirements as well as what not to do.  We expect our manufacturer trading partners to follow those guidelines and work with us in the unlikely event a problem arises.

Prescription drug packaging

For those manufacturers supplying prescription products, we require that all manufacturers follow the HDA Guidelines for Barcoding in the Pharmaceutical Supply Chain, which can be found here.

Consumer & medical device packaging

For those manufacturers supplying medical devices, or consumer products, we request that either GS1 or HIBCC identifiers are used and affixed in a barcode at all levels of product packaging.

Pharmaceutical contract manufacturer packaging requirements

For those partners providing contract packaging or manufacturing services to any of our AmerisourceBergen business units, including BluePoint, American Health Packaging or MWI, our packaging requirements can be found here.


Product setup and master data

Everything we do in our supply chain starts with accurate master product data.  Whether it be an inaccurate product identifier, missing hazmat values, or incorrect regulatory data missing or inaccurate master data can stop product movement through the supply chain.


AmerisourceBergen recently launched an interactive tool called ABC Setup that provides all manufacturers with an easy, automated interface for submitting new product information to AmerisourceBergen.   

ABC Setup can take consumer or medical device product data from a GS1 Data Synchronization Network (GDSN) or import the HDA New Product Form for prescription drug launches. Prior to submitting a new product request, ABC Setup will validate the key attributes and ensure that data errors aren’t passed downstream, resulting in hours of rework product stoppage.  

To get started, visit ABC Setup

We also continue to integrate key enhancements to ABC Setup that will allow us to receive a limited set of product changes (dimensions, quantities, etc.), further integrate the use of GDSN for DSCSA and potentially automate the HDA Rx New Product Form.

Useful links

GS1's Healthcare Global Trade Item Number™ (GTIN™) Allocation Rules
Explains when, how, and why Global Trade Item Numbers [GTINs] are created and assigned.  Anyone using GTINs or UPCs for product identification should review this document.

Healthcare Distribution Alliance (HDA) Rx Product Info Form
Current HDA New Product Form that must be used when uploading data into ABC Setup.  This form contains DSCSA and additional environment attributes required to safety move products.

GS1 US Implementation Guideline
This information covers implementing GS1 Standards, particularly the GS1 Electronic Product Code Information Services (EPCIS), for DSCSA lot-level management, serialization, and item-level traceability.


Manufacturer data exchange

AmerisourceBergen follows the American National Standards Institute X12 standard for EDI that complies with Healthcare Distribution Alliance (HDA) specifications. We support both the 4010 and 5010 versions of the standard as well as any new requirements or EDI document types that will emerge. As we lead the way in helping our manufacturer partners comply with DSCSA guidelines, we also support the evolving Electronic Product Code Information Services (EPCIS) standard for serialized data exchange.

EPCIS Data Exchange Information

AmerisourceBergen supports both EPCIS 1.1 and the newer EPCIS 1.2 for pharmaceutical products that have been assigned serial numbers (serialized) as DSCSA regulations require.

AmerisourceBergen Serialized Data Exchange Requirements 

Sample EPCIS files
- Sample EPCIS 1.2 AmerisourceBergen 
- Sample EPCIS 1.2 BluePoint Labs 
- Sample EPCIS 1.2 AHP
Sample EPCIS 1.2 MWI

AmerisourceBergen Location GLN/SGLN listing  

AmerisourceBergen Serialization Master Data Template


DSCSA Support for Customer/Dispensers

AmerisourceBergen (AB) intends to be fully compliant with the enhanced unit level tracking requirements by November 2023. At this time, AB does not believe the Food and Drug Administration (FDA) will provide any additional enforcement discretion. Prior to November 27, 2023, there are several key milestones that AB must complete to meet the November 2023 deadline while not disrupting patient access.

The Link to the guide below outlines the high-level steps required for customer onboarding for serialized data exchange with AmerisourceBergen. Our expectations are to complete the customer onboarding process by July 1, 2023.

Contact us

To start EPCIS onboarding, or to inquire about DSCSA or for any other related topics, our team is standing by to answer your questions.